|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Maternal serum interleukin-6 concentration in patients with preterm premature rupture of membranes and evidence of infection 显示文摘 | Murtha A P Phui|ip C G Jimmerson C E | 1996 | Am J Obstet Gynecol1996，175，： | 1 |
| 2 | 白细胞端粒长度缩短较动脉粥样硬化的临床表现提前出现:血液和肌肉模型显示文摘白细胞端粒长度与动脉粥样硬化性心血管病(atherosclerotic cardiovascular disease,ASCVD)相关。目前还不清楚这种关系是否源于出生时天生较短的白细胞端粒长度(leukocy tetelomere length,LTL)和(或)之后较快的LTL消耗。LTL代表高增殖性造血系统中的端粒长度,而骨骼肌中的端粒长度(muscle tetelomere length,MTL)代表最低限度复制的组织。 | Benetos A Toupance S Gautier S Labat C Kimura M Rossi PM Settembre N Hubert J Frimat L Bertrand B Boufi M Flecher X Sadoul N Eschwege P Kessler ML Tzanetakou IP Doulamis IP Konstantopoulos PS Tzani AI Korou LM Gkogkos A Perreas KG Menenakos E Samanidis G Vasiloglou-Gkanis M Kark JD Malikov S Verhulst S Aviv A 刘青 叶鹏 | 2018 | 中华高血压杂志2018，26，1： | 1 |
| 3 | Coherent detection in optical fiber systems 显示文摘 | Ip E Lau A P T Barros D J F | 2008 | Optics Express2008，16，2： | 1 |
| 4 | Improved Pt/Au and W/Pt/Au Schottky contacts on n-type ZnO using ozone cleaning显示文摘 | IP K GILA B P ONSTINE A H LAMBERS E S HEO Y W BAlK K H NORTON D P PEARTON S J KIM S LAROCHE J R REN F | 2004 | Appl Phys Lett2004，84，25： | 1 |
| 5 | Administration of the potent PPARalpha agonist,Wy-14,643,reverses nutritional fibrosis and steatohepatitis in mice显示文摘 | Ip E Farrell G Hall P | | 0，，： | 1 |
| 6 | Administration of the potent PPARalpha agonist, Wy- 14,643, reverses nutritional fibrosis and steatohepatitis in mice显示文摘 | IP E FARRELL G HALL P | 2004 | Hepatology2004，39，5： | 1 |
| 7 | 100G and beyond transmission technologies for evolving optical networks and relevant physical-layer issues显示文摘 | IP E JI P MATEO E | 2012 | Proceed- ings of the IEEE2012，100，5： | 1 |
| 8 | Acute effects of high fat and high glucose meals on the growth hormone response to exercise显示文摘 | CAPPON J IP P E BRASEL J A | 1993 | Clin Endocrinol Metab1993，79，： | 1 |
| 9 | Administration of the potent PPAR alpha agonist,Wy-14643,reverses nutritional fibrosis and steatohepatitis in mice显示文摘 | Ip E Farrel G C Hall P | 2004 | Hepatology2004，39，： | 1 |
| 10 | Tumorigenesis, metabolism, speciation, bioavailability and tissue deposition of selenium in selenium- enriched ramps(Allium tricoccum)显示文摘 | Whanger P D Ip C Polan C E | 2000 | Agric Food Chem2000，48，： | 1 |
| 11 | Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice 显示文摘 | Ip E Farrell G Hall P | 2004 | Hepatology2004，39，： | 1 |
| 12 | Determination of alendronate in pharmaceutical dosage formulations by ion chromatography with conductivity detection 显示文摘 | TSAI E W IP D P BROOKS M A | 1992 | J Chromatogr A1992，596，2： | 1 |
| 13 | Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice 显示文摘 | Ip E Fan'ell G Hall P | 2004 | Hepatology2004，39，5： | 1 |
| 14 | Administration of the Potent PPARalpha Agonist, Wy-14,643, Reverses Nutritional Fibrosis and Steatohepatitis In Mice显示文摘 | Ip E Farrell G Hall P | 2004 | Hepatology2004，39，5： | 1 |
| 15 | Coherent Detection in Optical Fiber Systems显示文摘 | IP E LAU A P T BARROS D J F | 2008 | Opt Express2008，16，： | 1 |
| 16 | The modified Cormack- Lehane score for the grading of direct laryngoscopy:evaluation in the Asian population显示文摘 | Koh L K Kong C E Ip Yam P C | 2002 | Anaesth Intensive Care2002，30，： | 1 |
| 17 | Coherent detection inoptical fiber systems 显示文摘 | IP E LAU A P T BARROS D J | 2008 | Optics Express2008，16，2： | 1 |
| 18 | Administration of the potent PPARalpha agonist, Wy-14 643, reverses nutritional fibrosis and steatohepatitis in mice显示文摘 | IP E FARRELL G HALL P | 2004 | Hepatology2004，39，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员